Introduction: Tumor growth and the ability to metastasize is a multistage process involving interactions between cancer cells and the vascular endothelium. These interactions have been reported to be mediated by various molecules including sVCAM-1. We have previously shown elevated serum concentration of sVCAM-1 in 82 neuroendocrine neoplasms (NEN) compared to controls. Here, we present results of the extension of the previous study.
Aim(s): To assess serum concentration of sVCAM-1 in extended cohort of NEN stratified into sub-groups based upon clinicopathological characteristics (TNM stage, tumor grade).
Materials and methods: The study group comprised 151 patients with NEN (PNEN 18%, SBNEN 15%, rectal NEN 16%, gastric NEN 9%, lung NEN 18%, CUP 13%, other 11%), and 28 sex and age-matched healthy controls. NEN at TNM stage I comprised 38%, stage II: 5%, stage III: 5%, stage IV: 52%. 61% of NEN were G1, G2: 21%, and G3: 18%.
Conference: 15th Annual ENETS conference 2018 (2018)
Presenting Author: MD PhD Violetta Rosiek
To read results and conclusion, please login ...
Further abstracts you may be interested in